The China National Intellectual Property Administration has released the list of demonstration objects from 2025 to 2027. This list aims to bolster China's position as a leading nation in intellectual property (IP). Among those selected is Jiangsu BioPerfectus Technologies in the Taizhou Medical High-tech Zone, Taizhou, Jiangsu province.
As a leading in vitro diagnostics enterprise in China, BioPerfectus has consistently prioritized core technology research and has integrated its IP strategy across the entire development cycle.
BioPerfectus is a leading in vitro diagnostic enterprise in China. [Photo/WeChat account: weigg6666]
The selection aims to cultivate a group of benchmarks, lead and drive the high-quality development of IP throughout the country.
In recent years, the zone has made significant advancements in its IP full chain service system. These improvements have strengthened its capacity to safeguard innovative achievements and facilitate the effective transformation of their value.
On the one hand, it has deepened its collaboration with the Taizhou Intellectual Property Protection Center and built a comprehensive, multi-level IP protection framework. On the other hand, it has accelerated the construction of municipal IP operation platforms, focusing on key links such as patent conversion and financial support, striving to enhance the effectiveness of IP transformation.